AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ferre, S
Popoli, P
Gimenez-Llort, L
Rimondini, R
Muller, CE
Stromberg, I
Ogren, O
Fuxe, K
Citation: S. Ferre et al., Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease, PARKINS R D, 7(3), 2001, pp. 235-241
Authors:
Popoli, P
Pezzola, A
Torvinen, M
Reggio, R
Pintor, A
Scarchilli, L
Fuxe, K
Ferre, S
Citation: P. Popoli et al., The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D-2 receptors in the rat striatum - Interactions with adenosine A(2a) receptors, NEUROPSYCH, 25(4), 2001, pp. 505-513
Authors:
Raschetti, R
Maggini, M
Da Cas, R
Popoli, P
Rossi, A
Citation: R. Raschetti et al., Time trends in the coprescribing of cisapride and contraindicated drugs inUmbria, Italy, J AM MED A, 285(14), 2001, pp. 1840-1841
Authors:
Pintor, A
Quarta, D
Pezzola, A
Reggio, R
Popoli, P
Citation: A. Pintor et al., SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum, EUR J PHARM, 421(3), 2001, pp. 177-180
Authors:
Pintor, A
Pezzola, A
Reggio, R
Quarta, D
Popoli, P
Citation: A. Pintor et al., The mGlu(5) receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A(2A) receptors, NEUROREPORT, 11(16), 2000, pp. 3611-3614
Authors:
Pintor, A
Potenza, RL
Domenici, MR
Tiburzi, F
Reggio, R
Pezzola, A
Popoli, P
Citation: A. Pintor et al., Age-related decline in the functional response of striatal group I mGlu receptors, NEUROREPORT, 11(13), 2000, pp. 3033-3038
Authors:
Stromberg, I
Popoli, P
Muller, CE
Ferre, S
Fuxe, K
Citation: I. Stromberg et al., Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A(2A) receptors in dopamine D-2 receptor regulation inthe rat dopamine-denervated striatum, EUR J NEURO, 12(11), 2000, pp. 4033-4037
Authors:
Popoli, P
Reggio, R
Pezzola, A
Citation: P. Popoli et al., Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats: Lack of tolerance after chronic caffeine intake, NEUROPSYCH, 22(5), 2000, pp. 522-529
Authors:
Ferre, S
Rimondini, R
Popoli, P
Reggio, R
Pezzola, A
Hansson, AC
Andersson, A
Fuxe, K
Citation: S. Ferre et al., Stimulation of adenosine A(1) receptors attenuates dopamine D-1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D-1 receptor-mediated turning behaviour, EUR J NEURO, 11(11), 1999, pp. 3884-3892
Authors:
Ferre, S
Popoli, P
Rimondini, R
Reggio, R
Kehr, J
Fuxe, K
Citation: S. Ferre et al., Adenosine A(2A) and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D-2 receptors in the rat striatum, NEUROPHARM, 38(1), 1999, pp. 129-140
Authors:
Popoli, P
Pezzola, A
Reggio, R
Tiburzi, F
Citation: P. Popoli et al., Selective agonists of metabotropic glutamate receptors elicit significant EEG effects when infused in the nucleus accumbens of rats, EUR J PHARM, 367(2-3), 1999, pp. 183-188
Authors:
Reggio, R
Pezzola, A
Popoli, P
Citation: R. Reggio et al., The intrastratial injection of an adenosine A(2) receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease, BRAIN RES, 831(1-2), 1999, pp. 315-318
Risultati:
1-12
|